NMS-873 --- ATPase VCP/p97 Inhibitor
Overview | |
Catalog # | bs-60165c-2mg-solid |
Product Name | NMS-873 --- ATPase VCP/p97 Inhibitor |
Specifications | |
Storage Buffer | Powder |
Storage Condition | Store in dry, dark place at -20C for 1 year. |
Target | |
Product Information | Molecular Weight: 520.67 Formula: C27 H28 N4 O3 S2 CAS Number: 1418013-75-8 InChi Key: UJGTUKMAJVCBIS-UHFFFAOYSA-N InChi: InChI=1S/C27H28N4O3S2/c1-19-16-22(11-14-25(19)20-9-12-24(13-10-20)36(2,32)33)34-18-26-29-30-27(35-23-7-3-4-8-23)31(26)21-6-5-15-28-17-21/h5-6,9-17,23H,3-4,7-8,18H2,1-2H3 Smiles: CC1C=C(C=CC=1C1C=CC(=CC=1)S(C)(=O)=O)OCC1=NN=C(SC2CCCC2)N1C1C=NC=CC=1 Purity: 98.0 Solubility: DMSO up to 10 mM Appearance: Solid Power. Shelf Life: 1.0 years |
Description | NMS-873 is a potent and specific small molecule allosteric inhibitor of the ATPase VCP/p97 (IC50 ~0.03 µM), identified by a high-throughput screening. It is very selective (IC50 >10 μM) against all of the AAA ATPases, HSP90 or the 53 kinases tested. Using photo-affinity labeling, structural analysis and mutagenesis, the binding site of NMS-873 was found to be a region spanning the D1 and D2 domains of adjacent protomers encompassing elements important for nucleotide-state sensing and ATP hydrolysis. NMS-873 activated the unfolded protein response, interfered with autophagy, and induced cancer cell death. NMS-873 provided critical validation of VCP as a cancer target, and it raises the possibility that targeting VCP might prevent proteasome inhibitor–resistant tumors from escaping through the aggresome-autophagy pathways and cause them to collapse under the high load of unfolded proteins. |